Human BDH2, an Anti-Apoptosis Factor, Is a Novel Poor Prognostic Factor for De Novo Cytogenetically Normal Acute Myeloid Leukemia

Journal of Biomedical Science - United Kingdom
doi 10.1186/1423-0127-20-58
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HES1 Is an Independent Prognostic Factor for Acute Myeloid Leukemia

OncoTargets and Therapy
OncologyPharmacology
2015English

Splicing Factor Mutations Predict Poor Prognosis in Patients With De Novo Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Overexpression of ATP1B1 Predicts an Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia

Oncotarget
Oncology
2015English

The Potassium Channel Ether a Go-Go Is a Novel Prognostic Factor With Functional Relevance in Acute Myeloid Leukemia

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

High Expression of RUNX1 Is Associated With Poorer Outcomes in Cytogenetically Normal Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

BAALC Expression: A Suitable Marker for Prognostic Risk Stratification and Detection of Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2014English

Gene and Protein Analysis Reveals That P53 Pathway Is Functionally Inactivated in Cytogenetically Normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia

BMC Medical Genomics
Genetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy